This compound is a protected amino acid building block used in pharmaceutical research. It features an Fmoc-protected amino group and a tert-butyl ester, along with an oxazolidine ring system that provides stereochemical control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 920519-32-0
Fmoc-Glu(OtBu)-Thr(psi(Me,Me)pro)-OH
research compound
Fmoc-Ser(tBu)-Thr(Psi(Me,Me)pro)-OH
research compound
Fmoc-Lys(Boc)-Thr(Psime,Mepro)-OH
research compound
Fmoc-Asn(Trt)-Thr(Psime,Mepro)-OH
research compound
L-Aspartic acid 1-tert-butyl ester
pharmaceutical intermediate
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-2,4-diaminobutyric acid
pharmaceutical intermediate
N-alpha-Cbz-D-2-4-diaminobutanoic acid
pharmaceutical intermediate
N-Formyl-4-(methylamino)benzoic acid
pharmaceutical intermediate
(4S,5R)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoyl]-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid
NKQJRYSIZOXCTJ-LAMXGVLKSA-N
C[C@@H]1[C@H](N(C(O1)(C)C)C(=O)[C@H](CC(=O)OC(C)(C)C)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O
—